CNTA Competitors & Alternatives
Compare Centessa Pharmaceuticals PLC ADR with similar stocks in the same industry
Biotechnology
CNTA
Main Stock$40.50
Tradestie Score
48
Market Cap
$3.03B
Analyst Upside
+9.1%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$56.18
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$113.95
|
$6.64B | - | 39 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.00
|
$6.38B | - | 62 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$20.41
|
$6.03B | - | 36 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.15
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$140.97
|
$5.92B | - | 60 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$64.26
|
$5.80B | 94.6 | 33 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$306.50
|
$5.20B | 41.2 | 51 | Compare |
More CNTA Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry